What is photodynamic therapy for CSR?

What is photodynamic therapy for CSR?

Photodynamic Therapy (PDT), introduced to ophthalmology in 2000, is a therapeutic procedure which utilizes the photosensitive intravenous drug, verteporfin (Visudyne, Bausch & Lomb) in combination with a low power, long duration infrared laser. In the eye, it is used to treat vascular issues in the retina and choroid.

What is photodynamic therapy for eyes?

Photodynamic therapy is a treatment for the eyes. It uses a laser and a special medicine that works when exposed to a certain type of light. It is done to treat age-related macular degeneration (AMD). AMD is a condition that can lead to loss of vision.

Can stress cause fluid behind eyes?

Stress causes the body to produce a hormone called cortisol. Cortisol can cause inflammation and leaks. This leakage may lead to fluid building up in the back of the eye.

Is central serous retinopathy autoimmune?

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with widespread manifestations including the eye. Central serous retinopathy (CSR) has been associated as a complicating event in SLE, although it is uncommon.

Is there a cure for Central Serous Chorioretinopathy?

Purpose: Central serous chorioretinopathy (CSCR) is an idiopathic disorder characterised by detachment of the neurosensory retina due to serous fluid accumulation between the photoreceptor outer segments and the retinal pigment epithelium. There are currently no set guidelines or protocols on its treatment.

How many eyes are affected by central serous chorioretinopathy?

In total, 117 citations were identified and 31 studies describing 787 eyes were included for review.

Is there a long-term treatment for CSCR with PDT?

There is sufficient scientific evidence to suggest that PDT may be a useful treatment option for chronic CSCR in the short-term. The review identifies a need for robust RCTs with longer follow-up to ascertain the role of PDT as a useful treatment option for CSCR. Photodynamic therapy for central serous chorioretinopathy Eye (Lond).